Document is current
Any future updates will be listed below
-
Authors
Frazzini, Valerio https://orcid.org/0000-0003-1187-3352
Mathon, Bertrand
Donneger, Florian
Cousyn, Louis
Hanin, Aurélie
Nguyen-Michel, V.-H.
Adam, Claude
Lambrecq, Virginie
Dupont, Sophie
Poncer, Jean Christophe
Bielle, Franck https://orcid.org/0000-0001-6564-6388
Navarro, Vincent https://orcid.org/0000-0003-0077-8114
-
Funding
Funding for this research was provided by:
ANR-10-IAIHU-06
the Fondation Assistance Publique Hôpitaux de Paris (EPIRES – Marie Laure PLV Merchandising).
- License Information
-
More Information
Article History
Received: 11 October 2021
Revised: 7 February 2022
Accepted: 11 February 2022
First Online: 7 March 2022
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Valerio Frazzini, Bertrand Mathon, Florian Donneger, Louis Cousyn, Aurélie Hanin, Vi-Huong Nguyen-Michel, Claude Adam, Virginie Lambrecq, Jean Christophe Poncer reports no disclosure. Sophie Dupont reports fees from Boards with UCB Pharma, EISAI, Liva Nova, GW Pharma, Takeda, Novartis. Franck Bielle reports funding of research out of the scope of this article by Abbvie, a next-of-kin employed by Bristol-Myers Squibb, fees of travel and conference out of the scope of this article by Bristol-Myers Squibb, Vincent Navarro reports fees from Boards with UCB Pharma, EISAI, Liva Nova, GW Pharma.
: The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
